Cite
MLA Citation
K Weiler et al.. “P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy.” Journal for immunotherapy of cancer, vol. 2, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100135548970.0x000004